期刊文献+

血清胆碱酯酶和补体C_3在肝硬化诊断中的临床价值 被引量:5

The Clinical Significance of Serum Cholinesterase and C_3 in Liver Cirrhosis
下载PDF
导出
摘要 背景:血清胆碱酯酶(CHE)和补体C_3由肝细胞合成,在肝硬化时其合成受到影响。因此血清CHE和补体C_3有可能成为评估肝硬化患者肝功能损伤的辅助指标。目的:探讨血清CHE、补体C_3在肝硬化诊断中的临床价值。方法:对我院2006年1月~2008年12月住院和门诊的262例肝硬化患者和92例正常对照者的血清CHE、补体C_3及血清白蛋白水平进行对照分析。结果:与正常对照组相比,肝硬化组患者血清CHE、补体C_3水平显著降低(P<0.01),血清白蛋白水平亦显著降低(P<0.05);血清CHE、补体C_3水平在不同Child-Pugh分级的肝硬化患者之间差异均有统计学意义(P<0.01);血清CHE、补体C_3水平随着Child-Pugh分级由A级至C级变化而逐渐降低。结论:血清CHE和补体C_3与肝功能损伤严重程度相关,结合Child-Pugh分级可更好地反映肝脏储备功能,并有利于帮助判断预后。 Background: Cholinesterase (CHE) and C3 are synthesized by hepatocytes and are affected in liver cirrhosis, they may be used to assess the liver damage in cirrhotic patients. Aims: To evaluate the clinical significance of CHE and C3 in liver cirrhosis. Methods: Two hundred and sixty-two outpatients and inpatients suffering from hepatic cirrhosis and 92 normal controls from January 2006 to December 2008 were enrolled in this study. Serum level of CHE, C3 and albumin were determined in each individual. Results: Comparing with normal controls, serum levels of CHE and Cz decreased significantly in cirrhotic patients (P〈0.01), same as serum albumin (P〈0.05). Serum levels of CHE and C3 had an inverse relationship with Child-Pugh grades of cirrhosis (P〈0.01). Conclusions: Serum CHE and C3 levels could reflect liver damage. The liver function reserve and the prognosis of liver cirrhosis could be better evaluated by serum levels of CHE and C3 in combination with Child-Pugh grades.
出处 《胃肠病学》 2009年第6期362-364,共3页 Chinese Journal of Gastroenterology
关键词 肝硬化 胆碱酯酶类 补体C3 Liver Cirrhosis Cholinesterase Complement C3
  • 相关文献

参考文献8

二级参考文献15

  • 1康格非 巫向前.临床生物化学和生物化学检验(第2版)[M].北京:人民卫生出版社,1999.154. 被引量:12
  • 2王昆.实用诊断酶学[M].北京:科技文献出版社,1989.23. 被引量:5
  • 3贾春华.肝病患者血清胆碱酯酶、总胆汁酸、前白蛋白的检测[J].白求恩医科大学学报,1999,25(4):492-492. 被引量:5
  • 4邓岩,刘小平.血清胆碱脂酶活力测定对慢性肝炎诊治的临床意义[J].重庆医学,1997,26(1):16-17. 被引量:23
  • 5Kondo M, Hada T, Fukui T, et al. Enzyme-linked immunosorbent assay(ELISA)for Aleuria aurantia lectinreactive serum cholinesterase to differentiate livw cirrhosis and chronic hepa-titis . Chin Chim Acta, 1995, 243:1-9. 被引量:1
  • 6叶任高主编.内科学:第5版[M].北京:人民卫生出版社,2000.798. 被引量:29
  • 7Jeffers LJ, Ceolho-Little ME, Cheinquer H, et al. Procollagen-Ⅲ peptide and chronic viral C hepatitis. Am J Gastroenterol, 1995,90:1437- 1440 被引量:1
  • 8Tsutsumi M, Urashima S, Matsuda Y, et al. Changes in type Ⅳ collagen in livers of patients with alcoholic liver disease. Hepatology, 1993,17:820-827 被引量:1
  • 9Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhisis. Gastroenterology, 1997,113:1609 - 1616 被引量:1
  • 10邓绪乐,邹正升.血清胆碱酯酶与病毒性肝炎肝组织病变的关系[J].中华肝脏病杂志,2000,8(2):120-120. 被引量:50

共引文献14141

同被引文献23

  • 1王临旭,黄长形,李新红,王毕娟,尹晨.慢性乙型肝炎病毒感染自然史中表面抗原水平的研究[J].中华临床医师杂志(电子版),2011,5(17):5122-5124. 被引量:7
  • 2杨洁,李建生.术前肝储备功能评估的研究进展[J].国际外科学杂志,2008,35(11):768-702. 被引量:1
  • 3杨爱,刘登涛.乙肝携带者乙肝表面抗原水平与胆碱酯酶活性关系.中华医学会第七次全国检验医学.学术会议资料汇编,2008:464. 被引量:1
  • 4Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA. Hepatitis Bsurface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010; 52:508-513. 被引量:1
  • 5Tian X, Li J, Ma ZM, Zhao C, Wan DF, Wen YM. Role of hepatitis B surface antigen in the develop- ment of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1. J Exp Clin Can- cer Res 2009; 28:58. 被引量:1
  • 6Wursthom K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, Longerich T, Schirmacher P, Metzler F, Zankel M, Fischer C, Currie G, Brosgart C, Petersen J. Peginterferon alpha-2b plus adefovir induce strong eccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 2006; 44:675-684. 被引量:1
  • 7Werle-Lapostolle B, Bowden S, Locarnini S, Wursthom K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney WE, Xiong S, Brosgart CL, Chen SS, Gibbs CS, Zoulim F. Persistence of cccD- NA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004; 126:1750-1758. 被引量:1
  • 8Wiegand J, Wedemeyer H, Finger A, Heidrich B, Rosenau J, Michel G, Boek CT, Manns MP, Tillmann HL. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels. Anti- vir Ther 2008; 13:547-554. 被引量:1
  • 9Noguchi C, Ishino H, Tsuge M, Fujimoto Y, lmamu- ra M, Takahashi S, Chayama K. G to A hypermuta- tion of hepatitis B virus. Hepatology 2005; 41:626-633.Brunetto MR. A new role for an old marker, HBsAg. J Hepato12010; 52:475477. 被引量:1
  • 10Brunet-to MR. A new role for an old marker, HBsAg. J Hepato12010; 52:475-477. 被引量:1

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部